0001104659-21-121632.txt : 20211001
0001104659-21-121632.hdr.sgml : 20211001
20211001081108
ACCESSION NUMBER: 0001104659-21-121632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210927
FILED AS OF DATE: 20211001
DATE AS OF CHANGE: 20211001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DHILLON PUNIT
CENTRAL INDEX KEY: 0001425052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54986
FILM NUMBER: 211297161
MAIL ADDRESS:
STREET 1: 5820 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arch Therapeutics, Inc.
CENTRAL INDEX KEY: 0001537561
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 460524102
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 235 WALNUT STREET, SUITE 6
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
BUSINESS PHONE: 617-431-2313
MAIL ADDRESS:
STREET 1: 235 WALNUT STREET, SUITE 6
CITY: FRAMINGHAM
STATE: MA
ZIP: 01702
FORMER COMPANY:
FORMER CONFORMED NAME: ALMAH,INC
DATE OF NAME CHANGE: 20111216
4
1
tm2129012d2_4.xml
FORM 4
X0306
4
2021-09-27
1
0001537561
Arch Therapeutics, Inc.
ARTH
0001425052
DHILLON PUNIT
C/O ARCH THERAPEUTICS, INC.
235 WALNUT STREET, SUITE 6
FRAMINGHAM
MA
01702
1
0
0
0
Stock Option (right to buy)
0.1028
2021-09-27
4
A
0
250000
0
A
2031-09-26
Common Stock
250000
250000
D
Stock Option (right to buy)
0.1028
2021-09-27
4
A
0
250000
0
A
2031-09-26
Common Stock
250000
250000
D
The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.
The option was granted pursuant to the Plan. 1/3 of the option vested on the grant date and the remainder of the option shall vest equally on each of the first 24 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.
/s/ Punit Dhillon
2021-09-30